Intelligence / Healthtech / New Clinical Trials / My Myracle Sdn.Bhd
Clinicaltrial registered18 Nov 2026
My Myracle Sdn.Bhd
18 Nov 2026: Trial registered · Effects of PosBion® Supplementation on Intestinal Barrier Function in Adults With Irritable Bowel Syndrome. Recorded in the ClinicalTrials.gov (US National Library of Medicine).
- Posted
- 18 Nov 2026
- Title
- Effects of PosBion® Supplementation on Intestinal Barrier Function in Adults With Irritable Bowel Syndrome
- Conditions
- Irritable Bowel Syndrome (IBS)
- Phase
- Not applicable
- Study Type
- Interventional
- Status
- Not Yet Recruiting
- Countries
- Malaysia
- Country
- Malaysia
- Reference
- NCT07947290
- Location
- Malaysia
What this signal means
A new trial needs sites, patients, data capture, monitoring and regulatory partners for years.
- United States leads with 192 of 777, then China (171).
- 777 added in the 30 days to 18 Nov 2026.
Reach them with AOS
Find the decision makers at My Myracle Sdn.Bhd
AOS maps the buying committee, finds verified work emails and drafts outreach that cites this clinical signal, for your approval.
More from Malaysia
New Clinical Trials
12 NovAstraZenecatrial registered · A Phase III Study to Assess the Effect of FDC Laroprovstat/Rosuvastatin Compared With Laroprovstat, Rosuvastatin, and Placebo on LDL-C in LLT-naïve PatientsClinical4 NovBoehringer Ingelheimtrial registered · A Study to Learn How Well People With Bronchiectasis Tolerate Continued Treatment With Verducatib After Earlier Studies (AIRTIVITY®-ON)Clinical3 NovCOSMEDICIAN AP SDN BHDtrial registered · Pilot Study of Combination Treatment With Subcision, Human Adipose Tissue-Derived Exosomes and Powdered Polydioxanone for Atrophic Acne ScarsClinical3 NovPharmaResearch Co.,Ltdtrial registered · Clinical Research on Deep-Plane Rejuran S Injection for Improvement in the Apperance of Periorbital Hollowing Using a Cannula TechniqueClinical3 NovPharmaResearch Co.,Ltdtrial registered · Clinical Evaluation of Dual-Plane Technique PN-Based Treatment for Horizontal Neck Lines Using DNA Fragment Opmizing Technology Polynucleotide (DOT PN)Clinical30 OctBoehringer Ingelheimtrial registered · The AIRWARD Study: A Study to Test Whether Verducatib Helps People With Chronic Obstructive Pulmonary DiseaseClinical
Source: ClinicalTrials.gov (US National Library of Medicine), data to 18 Nov 2026. Trials first posted in the window whose lead sponsor is a company, worldwide. Device and diagnostic studies usually have no phase. AOS shows what the public record says; it does not verify or endorse the company.